Brief: 3SBio Inc Says Clinical Trial Application Of Group's Hif-117 Capsule Approved By NMPA
13/11/2019 14:13
Nov 13 (Reuters) - 3SBio Inc 1530.HK :
* CLINICAL TRIAL APPLICATION OF GROUP'S HIF-117 CAPSULE HAS
BEEN
APPROVED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Source text for Eikon: ID:nHKSsz3HK
Further company coverage: 1530.HK
((Reuters.Briefs@thomsonreuters.com;))